Migraine cost-effectiveness of therapy: Difference between revisions
Kiran Singh (talk | contribs) |
m (Bot: Removing from Primary care) |
||
| Line 13: | Line 13: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Migraine]] | [[Category:Migraine]] | ||
[[Category:Neurology]] | [[Category:Neurology]] | ||
[[Category:Emergency medicine]] | [[Category:Emergency medicine]] | ||
Latest revision as of 22:43, 29 July 2020
|
Migraine Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Migraine cost-effectiveness of therapy On the Web |
|
American Roentgen Ray Society Images of Migraine cost-effectiveness of therapy |
|
Risk calculators and risk factors for Migraine cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Treatments are typically expensive. Periodic or unpredictable disability can cause impoverishment due to patients' inability to work enough or to hold a job at all.
Cost-Effectiveness of Therapy
In addition to being a major cause of pain and suffering, chronic migraine attacks are a significant source of both medical costs and lost productivity. Medical costs per migraine sufferer (mostly physician and emergency room visits) averaged $107 USD over six months in one 1988 study, with total costs including lost productivity averaging $313. Annual employer cost of lost productivity due to migraines was estimated at $3,309 per sufferer. Total medical costs associated with migraines in the United States amounted to one billion dollars in 1994, in addition to lost productivity estimated at thirteen to seventeen billion dollars per year. Employers may benefit from educating themselves on the effects of migraines in order to facilitate a better understanding in the workplace. The workplace model of 9-5, 5 days a week may not be viable for a migraine sufferer. With education and understanding an employer could compromise with an employee to create a workable solution for both.